ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 DiabetesMichael Brines, Albert Dahan, Ioannis N. Petropoulos et al.|Molecular Medicine|2014Cited by 143
Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic PainDaniel A. Culver, Michael Brines, Albert Dahan et al.|Investigative Ophthalmology & Visual Science|2017Cited by 103
A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular EdemaNoemi Lois, Michael Brines, Anthony Cerami et al.|Journal of Clinical Medicine|2020Cited by 11